System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live2m

Terminal Asset View

stockNASDAQ

BCAB

$0.17-1.90%

BioAtla Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

15Neutral

Live Analysis Active

Company Mission

BioAtla creates special proteins called antibodies that target cancer cells more precisely than traditional treatments. These therapies are designed for patients with specific types of cancer who need more effective options. The company makes money through partnerships with larger pharmaceutical companies and by advancing its treatments through clinical trials toward potential approval and sales.

BCA

Industry Context

The biotech industry focuses on developing medical treatments using biological systems. Companies in this space often work on innovative therapies for diseases like cancer, which can be high-risk but potentially high-reward if successful.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

46Matrix

Market Momentum

38.4— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.5x— Normal Volume

Today's Change

-1.90%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BCAB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:58 AM UTC

As-of 03-15-2026 03:42 UTC

Develops cancer drugs that target tumors based on their environment and makes money by licensing these treatments to pharmaceutical companies.

Price is compressing on the weekly chart, suggesting potential volatility expansion soon showing consolidation pattern.

Biotech sector shows renewed interest in targeted therapies, which could benefit companies with novel approaches like Bioatla.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...